BCR and infection: To confirm that both polyreactive and non-polyreactive MAbs could be activated upon encounter with SARS-CoV-2 S as could occur during infection or vaccination, we engineered Ramos B cells to express a BCR that incorporates the variable regions of MAbs 1C12 and 3C9, both originally derived from naive S-reactive B cells.